Treasury Department’s Take on U.S. Reliance on China for Critical Industries
In a recent discussion, Treasury Secretary Scott Bessent shared insights with Breitbart Business Digest, emphasizing the Trump administration’s commitment to reducing America’s reliance on China for essential materials and medicines. He referred to this initiative as “reclaiming our sovereignty.”
During a conversation held in the historic Treasury Building, Bessent outlined a strategy focused on “reducing risk, not decoupling” from China, particularly in sectors like rare earths, pharmaceuticals, semiconductors, steel, and shipbuilding.
Understanding America’s Rare Earth Challenges
Bessent labeled the current vulnerability of the U.S. as “inexcusable,” attributing it to the concept of unrestricted free trade. He pointed out that rare earth magnet technology, which originated in the U.S., has been turned against American interests.
He noted that the core technology for modern rare earth magnets was developed by General Motors but eventually sold to a Chinese firm. This company, after a five-year requirement to maintain operations in the U.S., promptly relocated to China.
Bessent remarked, “In one day they moved it to China.” Since then, he argues, China has employed predatory dumping tactics whenever American firms try to establish rare earth facilities. He added that there’s a significant amount of unfair competition without any governmental intervention.
This ongoing cycle of Chinese dumping and U.S. inaction has created what Bessent described as built-in obstacles to attracting investment in rare earth production in the U.S. Investors are understandably wary, fearing that the government won’t act against Chinese producers who could undercut prices and drive competitors out of business.
Bessent recounted that during Trump’s first term, attempts were made to tackle this issue, but environmentalist opposition thwarted progress.
Resurgence of Rare Earth Manufacturing in the U.S.
Currently, some significant advancements are being made. Bessent highlighted a facility in Sumter, South Carolina, where the first rare earth magnets made in the U.S. in 25 years have recently been produced. This project has created 300 jobs, along with 800 construction positions, and there is potential for expansion that could lead to 3,000 additional jobs.
The situation in Sumter exemplifies Bessent’s point about ongoing “reindustrialization.” Once home to Caterpillar—its largest private employer—Sumter saw job losses when the factory closed, but now former Caterpillar workers are contributing to the rare earth magnet industry.
Bessent shared a conversation with the factory manager regarding hiring practices, mentioning that many new hires were long-time employees who remained loyal to Caterpillar.
Pharmaceutical Industry Vulnerabilities
Delving into pharmaceuticals, he described critical vulnerabilities, noting that 70 to 90 percent of drug precursor chemicals originate from China. These chemicals are vital for domestic pharmaceutical production, without which U.S. companies cannot manufacture finished products.
Particularly concerning is amoxicillin, a commonly prescribed antibiotic, for which China controls 100 percent of the production. “We are incredibly vulnerable,” Bessent stated, while also observing that China maintains strategic restraint over the supply of drug precursors, which still poses a risk.
Aiming for Risk Reduction
The administration’s goal, according to Bessent, isn’t to cut ties with China entirely but rather to reduce their monopoly over key industries. “We don’t have to cut ourselves off from China; we just have to mitigate the risk,” he explained.
A clear message has been communicated to pharmaceutical companies: they are expected to bring production back to the U.S. This approach represents a significant shift from past policies that many administrations avoided. While resistance may lead to higher tariffs, the specific consequences of not complying were less defined.
Bessent noted that many companies hesitated to take on risks due to the complexities involved, but under Trump’s direction, there was a strong message that production needed to return.
Future Prospects
In addition, Bessent pointed to the expansion of Boeing’s Charleston facility, which is set to grow its Dreamliner operations by 50%, creating 1,000 high-paying jobs.
Looking ahead, Bessent expressed optimism about managing U.S.-China relations, believing there is potential for a calmer approach in the coming year.
Rebuilding America’s Industrial Base
The broader theme underlying these efforts relates to the need for a stronger industrial base in America. Bessent underlined the importance of ensuring that both Wall Street and Main Street thrive, especially for working-class individuals who have felt neglected by past trade decisions that favored abstract economic theories over the nation’s welfare.
Throughout his discussions, Bessent consistently returned to the idea of sovereignty and the urgency of reinvigorating America’s industrial capabilities. The initiatives surrounding rare earths and pharmaceutical production are early steps toward redefining the U.S.-China economic relationship—not from a place of hostility but rather necessity.
“We are taking back our sovereignty,” Bessent concluded, as the Trump administration embarks on restoring what has been lost over the years in key sectors.
